ArticleFrontiers in immunology2024

Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening.

Siyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.